Brewin Dolphin Wealth Management’s Kyntra Bio KYNB Stock Holding History

Brewin Dolphin Wealth Management’s Portfolio KYNB Stock Details KYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$3K	Hold	10	–	–	﹤0.01%	319
2022 Q1	$3K	Hold	10	–	–	﹤0.01%	347
2021 Q4	$4K	Hold	10	–	–	﹤0.01%	304
2021 Q3	$2.56K	Hold	10	–	–	﹤0.01%	325
2021 Q2	$6.66K	Hold	10	–	–	﹤0.01%	306
2021 Q1	$8.68K	Sell	10 -15	-60%	-$16K	﹤0.01%	288
2020 Q4	$23.4K	Hold	25	–	–	﹤0.01%	219
2020 Q3	$25.9K	Hold	25	–	–	﹤0.01%	204
2020 Q2	$25.5K	Hold	25	–	–	0.01%	196
2020 Q1	$21.9K	Hold	25	–	–	0.01%	140
2019 Q4	$27K	Hold	25	–	–	0.01%	150
2019 Q3	$23.3K	Hold	25	–	–	0.01%	145
2019 Q2	$28.5K	Hold	25	–	–	0.01%	138
2019 Q1	$34.2K	Hold	25	–	–	0.02%	123
2018 Q4	$29.2K	Hold	25	–	–	0.02%	123
2018 Q3	$38.3K	Hold	25	–	–	0.02%	120
2018 Q2	$39.4K	Hold	25	–	–	0.02%	116
2018 Q1	$29.1K	Buy	+25	New	+$32.9K	0.02%	124

Other funds holding KYNB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Brewin Dolphin Wealth Management's KYNB Position: Q2 2022 in Review

Brewin Dolphin Wealth Management held its Kyntra Bio (KYNB) position steady in Q2 2022 at 10 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #319.

Brewin Dolphin Wealth Management first reported a position in KYNB in Q1 2018 and has held it in 18 quarters since. The position peaked at $39.4K in Q2 2018. 150 funds tracked by Wall St. Rank hold KYNB as of Q2 2022.

Brewin Dolphin Wealth Management held 10 shares of Kyntra Bio worth $3K as of Q2 2022.
Brewin Dolphin Wealth Management left its Kyntra Bio share count unchanged in Q2 2022.
Kyntra Bio made up ﹤0.01% of Brewin Dolphin Wealth Management's portfolio in Q2 2022, its #319 holding.
Brewin Dolphin Wealth Management first reported a position in Kyntra Bio in Q1 2018 and has held it in 18 quarters since.
Brewin Dolphin Wealth Management's Kyntra Bio position peaked at $39.4K in Q2 2018.
150 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2022.

Based on Brewin Dolphin Wealth Management's 13F filing for Q2 2022, filed 14 Nov 2022.